Drug-Related Side Effects and Adverse Reactions
Drug-Related Side Effects and Adverse Reactions
Explore linked clinical trials. Standard reference: MESH:M0581793227 results · Page 1 of 10
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cardiac Biomarkers in Patients Receiving Immune Checkpoint Inhibitors (PRIME-ICI) | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury | Not yet recruiting | Not stated | 2026-10-08 | NCT07864727 | |
| A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Nausea, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting, neoplasm | Recruiting | Phase 2 | 2026-10-08 | NCT07169851 | |
| Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer | Adnexal Diseases, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, drug allergy, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, uterine disorder | Recruiting | Not applicable | 2026-10-07 | NCT06977594 | |
| Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE) | Arrhythmias, Cardiac, Blood Protein Disorders, Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Ventricular Dysfunction, Ventricular Dysfunction, Left, breast cancer, breast disorder, breast neoplasm, cancer, cardiovascular disorder, heart disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, injury, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, radiation injury, skin disorder, vascular disorder, vascular hemostatic disease | Not yet recruiting | Not applicable | 2026-10-06 | NCT07776964 | |
| Novel On-body Evaluation of Cardiac Health for Oncology | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, heart failure, injury, radiation injury | Enrolling by invitation | Not stated | 2026-10-05 | NCT07158450 | |
| Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, cardiovascular disorder, heart disorder, injury, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, radiation injury, respiratory system disorder, respiratory tract neoplasm, skin disorder | Active, not recruiting | Not stated | 2026-10-05 | NCT06332131 | |
| Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors | Arrhythmias, Cardiac, B-cell chronic lymphocytic leukemia, Cardiotoxicity, Chemically-Induced Disorders, Chronic Disease, Disease Attributes, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, hematologic disorder, hypertensive disorder, immune system disorder, immunoproliferative disorder, injury, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm, radiation injury, vascular disorder | Enrolling by invitation | Not stated | 2026-10-05 | NCT06211413 | |
| Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury, skin disorder | Active, not recruiting | Not stated | 2026-10-05 | NCT05036252 | |
| Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, cardiovascular disorder, heart disorder, injury, lung disorder, lung neoplasm, neoplasm, radiation injury, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not stated | 2026-10-05 | NCT04305613 | |
| Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury | Active, not recruiting | Phase 4 | 2026-10-02 | NCT04939883 | |
| Cardioprotection Effect of Linagliptin | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, injury, radiation injury | Not yet recruiting | Phase 3 | 2026-10-01 | NCT07852546 | |
| Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin | Chemically-Induced Disorders, Drug-Induced Ototoxicity, Drug-Related Side Effects and Adverse Reactions, Ear Diseases, Neurologic Manifestations, Ototoxicity, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, hearing disorder, hearing loss disorder, injury, nervous system disorder, otorhinolaryngologic disease, radiation injury | Recruiting | Phase 2 | 2026-10-01 | NCT05730283 | |
| IPGx PILOT Whole Genome Sequencing Extension Cohort | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions | Recruiting | Not stated | 2026-09-30 | NCT06766071 | |
| SAMe in Prevention of Oxaliplatin-associated Liver Injury | 5-fluorouracil toxicity, Chemically-Induced Disorders, Chemically-Induced Liver Toxicity, Digestive System Diseases, Digestive System Neoplasms, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, cardiovascular disorder, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, drug-induced liver injury, hepatic veno-occlusive disease, intestinal disorder, liver disorder, neoplasm, poisoning, rectal disorder, vascular disorder | Not yet recruiting | Phase 2 | 2026-09-30 | NCT06258525 | |
| Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. | Arrhythmias, Cardiac, Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute coronary syndrome, cardiovascular disorder, heart disorder, hypertensive disorder, injury, lung disorder, myocardial ischemia, pulmonary hypertension, radiation injury, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-09-25 | NCT07157670 | |
| Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, immune system disorder, immunoproliferative disorder, injury, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma, radiation injury, skin disorder | Not yet recruiting | Phase 1 | 2026-09-24 | NCT07838649 | |
| Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma | B-cell neoplasm, Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, diffuse large B-cell lymphoma, heart disorder, heart failure, histiocytosis, immune system disorder, immunoproliferative disorder, injury, interdigitating dendritic cell sarcoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, malignant histiocytosis, neoplasm, radiation injury | Recruiting | Phase 3 | 2026-09-23 | NCT06220032 | |
| Misocholic Tablets for Non-Viral Elevated Liver Enzymes | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, poisoning | Not yet recruiting | Phase 3 | 2026-09-22 | NCT07833514 | |
| Prevalence and Prognosis of Drug-Induced Liver Injury | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, Hepatic Insufficiency, acute liver failure, drug-induced liver injury, liver disorder, liver failure, poisoning | Not yet recruiting | Not stated | 2026-09-21 | NCT07830901 | |
| Real World Asparaginase Therapy Toxicity | Chemically-Induced Disorders, Drug Toxicity, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute biphenotypic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Not stated | 2026-09-17 | NCT07008027 | |
| Cardiac Side Effects of Systemic Therapy in Early-Stage Breast Cancer | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury, skin disorder | Recruiting | Not stated | 2026-09-16 | NCT07588425 | |
| Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, cardiovascular disorder, heart disorder, injury, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, radiation injury, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-09-15 | NCT07761910 | |
| Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, carcinoid syndrome, carcinoid tumor, carcinoma, cecum neuroendocrine tumor G1, enterochromaffin cell serotonin-producing pancreatic neuroendocrine tumor, epithelial neoplasm, ileal neuroendocrine tumor G1, intestinal neuroendocrine tumor G1, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, serotonin syndrome | Recruiting | Phase 3 | 2026-09-15 | NCT07087054 | |
| Citalopram and the Risk of Serious Adverse Events | Chemically-Induced Disorders, Chronic Disease, Disease Attributes, Drug-Related Side Effects and Adverse Reactions, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Not stated | 2026-09-14 | NCT07399795 | |
| Sertraline and the Risk of Serious Adverse Events | Chemically-Induced Disorders, Chronic Disease, Disease Attributes, Drug-Related Side Effects and Adverse Reactions, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Not stated | 2026-09-14 | NCT07387120 |